Concepedia
Statistics
Publications
27
Citations
934
H-Index
19
Active since
2017
Affiliations
St. John's University(Current)
Tianjin Medical University
Guangzhou Medical University
Guizhou University
National Cancer Institute
Ning Ji is an author at St. John's University specializing in medicine, pharmacology, and cell biology.
Top concepts
MedicineCell BiologyPharmacologyTumor BiologyCancer ResearchDrug ResistanceBiologyGeneticsOncologyCancer Biology
Publications per year
2017–2024
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
Ning Ji, Yuqi Yang, Chao‐Yun Cai et al. · Cancer Letters · 2018 · 105 citations · Full text
Abcg2-overexpressing Cancer Cells, Oncology, Medicine +9
Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression
Shuai Wang, Lingyi Zhou, Ning Ji et al. · Drug Resistance Updates · 2023 · 82 citations
Acyp1-mediated Glycolysis Reverses, Tumor Biology, Medicine +11
VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
Ning Ji, Yuqi Yang, Chao‐Yun Cai et al. · Frontiers in Pharmacology · 2018 · 72 citations · Full text
Abc Transporters, Atpase Analysis, Cancer Biology +18
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Ning Ji, Yuqi Yang, Zi‐Ning Lei et al. · Biochemical Pharmacology · 2018 · 66 citations
Molecular Pharmacology, Medicinal Chemistry, Medicine +6
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
Jing‐Quan Wang, Jonathan Y. Li, Qiu‐Xu Teng et al. · Cancers · 2020 · 51 citations · Full text
Bcl-2 Inhibitor, Immunology, Immunotherapeutics +18
1–5 of 27